Difference between revisions

Mitochondrial dysfunction in aging

What changed between revision 1 and revision 2, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.

95 lines touched77 added0 removed18 rewritten−79 bytes

Older · revision 1

28 July 2026 at 17:44 UTC

Import· initial corpus import, not an edit

Initial import of content/mitochondrial-dysfunction.md — the filesystem corpus, unchanged. Not an edit.

12.8 kB

Newer · revision 2

29 October 2026 at 07:38 UTC

Import

Re-import of content/mitochondrial-dysfunction.md — the file changed after the initial import. Not an edit.

12.7 kB

Revision 1

Revision 2

lines 7–13 → 7–136 unchanged lines not shown

categories: ["longevity"]

tags: ["aging", "mitochondria", "oxidative stress", "mtdna", "metabolism", "mechanisms"]

summary: "Age-related decline in mitochondrial energy production, quality control and signalling, once explained by free-radical damage and now understood as a more tangled process."

summary: "Age-related decline in mitochondrial energy production, quality control and signalling, once explained by free-radical damage and now understood as a more tangled process."

updated: "2026-07-27"

updated: "2026-10-29"

humanEvidence: "Falling respiratory capacity and clonally expanded mtDNA deletions are documented in aged human muscle and brain tissue; antioxidant trials in people found no mortality benefit and signals of harm."

humanEvidence: "Falling respiratory capacity and clonally expanded mtDNA deletions are documented in aged human muscle and brain tissue; antioxidant trials in people found no mortality benefit and signals of harm."

issues: ["The 2005 mitochondria-targeted catalase result in the timeline carries no citation."]

---

lines 27–85 → 27–16213 unchanged lines not shown

}

```

**Mitochondrial dysfunction in aging** refers to the progressive loss of mitochondrial respiratory capacity, genome integrity, and quality control that accompanies age in most tissues studied. It is classed as an antagonistic hallmark in the [[hallmarks-of-aging]] framework, meaning the underlying responses are protective at low intensity and damaging when chronic. The mechanism was long assumed to be self-amplifying oxidative damage; that explanation has not survived the experiments designed to test it.

**Mitochondrial dysfunction in aging** refers to the progressive loss of mitochondrial respiratory

capacity, genome integrity and quality control that accompanies age in most tissues studied. The

[[hallmarks-of-aging]] framework classes it as an antagonistic hallmark, meaning that the underlying

responses protect at low intensity and do damage when chronic. The mechanism was long assumed to be

self-amplifying oxidative damage, an explanation that has not survived the experiments designed to

test it.

## What declines

Mitochondria generate most cellular ATP through oxidative phosphorylation, buffer calcium, synthesize iron–sulfur clusters and steroid hormones, and control the intrinsic apoptosis pathway. Each carries multiple copies of a circular genome of roughly 16.5 kilobases encoding 37 genes, of which 13 are protein subunits of the respiratory chain; the remaining thousand-odd mitochondrial proteins are encoded in the nucleus and imported.

Mitochondria generate most cellular ATP through oxidative phosphorylation. They also buffer calcium,

synthesize iron-sulfur clusters and steroid hormones, and control the intrinsic apoptosis pathway.

Each carries multiple copies of a circular genome of roughly 16.5 kilobases encoding 37 genes, 13 of

which are protein subunits of the respiratory chain; the remaining thousand-odd mitochondrial

proteins are encoded in the nucleus and imported.

With age, measured respiratory capacity per unit of mitochondrial mass falls in muscle, liver and brain; mitochondrial morphology becomes more heterogeneous; membrane potential declines in a subset of organelles; and damaged mitochondria are cleared more slowly. In aged human skeletal muscle, individual fibres appear that lack cytochrome c oxidase activity, each traceable to a clonally expanded mitochondrial DNA deletion. Comparable clonal expansions of mtDNA deletions accumulate in substantia nigra neurons.[^bender2006] These are focal, cell-by-cell failures rather than a uniform organism-wide dimming.

With age, measured respiratory capacity per unit of mitochondrial mass falls in muscle, liver and

brain. Mitochondrial morphology becomes more heterogeneous, membrane potential declines in a subset

of organelles, and damaged mitochondria are cleared more slowly. Aged human skeletal muscle contains

individual fibres that lack cytochrome c oxidase activity, each traceable to a clonally expanded

mitochondrial DNA deletion. Comparable clonal expansions of mtDNA deletions accumulate in substantia

nigra neurons.[^bender2006] These are focal failures, cell by cell, and not a uniform dimming across

the organism.

## The free-radical theory and its decline

Denham Harman proposed in 1956 that aging results from cumulative damage by free radicals produced during normal metabolism, and in 1972 localized the main source to mitochondria.[^harman1956] The theory was attractive because it linked metabolic rate, damage, and lifespan in one causal chain, and it dominated the field for four decades. It also generated a clear prediction: reducing oxidative damage should extend lifespan.

Denham Harman proposed in 1956 that aging results from cumulative damage by free radicals produced

during normal metabolism, and in 1972 he placed the main source in mitochondria.[^harman1956] The

theory linked metabolic rate, damage and lifespan in one causal chain, and it dominated the field

for four decades. It also made a clear prediction: reducing oxidative damage should extend lifespan.

```timeline

[

  { "year": "1956", "title": "Free-radical theory proposed", "text": "Denham Harman argues that oxygen radicals produced by metabolism damage cells cumulatively and cause aging." },

  { "year": "1956", "title": "Free-radical theory proposed", "text": "Denham Harman argues that oxygen radicals produced by metabolism damage cells cumulatively and cause aging." },

  { "year": "2004–2005", "title": "Mutator mice", "text": "Mice carrying a proofreading-deficient mitochondrial polymerase accumulate mtDNA mutations and show premature aging phenotypes, at mutation loads far above those seen in normal aging." },

  { "year": "2004-2005", "title": "Mutator mice", "text": "Mice carrying a proofreading-deficient mitochondrial polymerase accumulate mtDNA mutations and show premature aging phenotypes, at mutation loads far above those seen in normal aging." },

  { "year": "2005", "title": "One clean positive", "text": "Targeting catalase to mitochondria extends median mouse lifespan by roughly a fifth, the strongest single result supporting the oxidative theory." },

  { "year": "2005", "title": "One clean positive", "text": "Targeting catalase to mitochondria extends median mouse lifespan by roughly a fifth, the strongest single result supporting the oxidative theory." },

  { "year": "2007–2011", "title": "Antioxidant trials fail", "text": "Meta-analyses of antioxidant supplement trials find no mortality benefit, and vitamin E is associated with increased prostate cancer risk in a large prevention trial." },

  { "year": "2007-2011", "title": "Antioxidant trials fail", "text": "Meta-analyses of antioxidant supplement trials find no mortality benefit, and vitamin E is associated with increased prostate cancer risk in a large prevention trial." },

  { "year": "2009", "title": "Genetic tests come back negative", "text": "A review of mouse models altering antioxidant enzymes finds that most changes to oxidative defences do not alter lifespan." },

  { "year": "2009", "title": "Genetic tests come back negative", "text": "A review of mouse models altering antioxidant enzymes finds that most changes to oxidative defences do not alter lifespan." },

  { "year": "2013", "title": "Mutation signature reinterpreted", "text": "Sequencing of aged human brain shows mtDNA mutations carry a replication-error signature rather than an oxidative-damage signature." }

  { "year": "2013", "title": "Mutation signature reinterpreted", "text": "Sequencing of aged human brain shows mtDNA mutations carry a replication-error signature rather than an oxidative-damage signature." }

]

```

Nearly every direct test failed. Overexpressing or deleting superoxide dismutases and glutathione peroxidases in mice generally changed oxidative damage markers without changing lifespan.[^perez2009] Large randomized trials and meta-analyses of [[dietary-supplements|antioxidant supplements]] found no reduction in all-cause mortality, with signals of harm for some agents.[^bjelakovic2007] Long-lived species do not consistently show lower radical production; naked mole-rats carry high levels of oxidative damage while living an order of magnitude longer than mice of similar size, a comparison that features in the literature on [[negligible-senescence|negligible senescence]].

Nearly every direct test failed. In mice, overexpressing or deleting superoxide dismutases and

glutathione peroxidases generally changed markers of oxidative damage without changing

lifespan.[^perez2009] Large randomized trials and meta-analyses of

[[dietary-supplements|antioxidant supplements]] found no reduction in all-cause mortality, with

signals of harm for some agents.[^bjelakovic2007] Long-lived species do not consistently produce

fewer radicals. Naked mole-rats carry high levels of oxidative damage yet live an order of magnitude

longer than mice of similar size, a comparison that features in the literature on

[[negligible-senescence|negligible senescence]].

The interpretation that replaced it is mitohormesis: modest reactive oxygen species act as signals that trigger adaptive responses, and blunting them removes a stimulus the cell needs. In *Caenorhabditis elegans*, increasing mitochondrial superoxide can extend lifespan, and antioxidant treatment abolishes the effect. The same logic explains why antioxidant supplementation can blunt some of the adaptations produced by [[exercise-and-aging|exercise training]].

The interpretation that replaced the theory is mitohormesis. In this view, modest levels of reactive

oxygen species act as signals that trigger adaptive responses, and blunting them removes a stimulus

the cell needs. In *Caenorhabditis elegans*, increasing mitochondrial superoxide can extend

lifespan, and antioxidant treatment abolishes the effect. The same logic explains why antioxidant

supplementation can blunt some of the adaptations to [[exercise-and-aging|exercise training]].

> [!key] Why the reversal matters

> The failure of antioxidants is the clearest case in biogerontology of a mechanistically appealing theory that did not survive intervention studies. It is the standard example cited against reasoning from plausible mechanism to expected benefit, and it is why the field now insists on lifespan and function endpoints rather than damage markers.

> The failure of antioxidants is biogerontology's clearest case of a mechanistically appealing

> theory that did not survive intervention studies. It is the standard example cited against

> reasoning from plausible mechanism to expected benefit, and it is why the field now insists on

> lifespan and function endpoints instead of damage markers.

## mtDNA mutation and heteroplasmy

Because each cell carries many mitochondrial genomes, mutations exist as a mixture with wild-type copies, a condition called heteroplasmy. A biochemical defect usually appears only when mutant load in a cell exceeds a threshold, commonly placed between roughly 60 and 90 percent depending on the mutation and tissue. Aging tissue shows a rise not in average mutation burden across all copies, which stays low, but in the number of individual cells that have crossed the threshold through clonal expansion of a single mutant lineage.

Each cell carries many mitochondrial genomes, so mutations exist as a mixture with wild-type copies,

a condition called heteroplasmy. A biochemical defect usually appears only when the mutant load in a

cell exceeds a threshold, commonly placed between roughly 60 and 90 percent depending on the

mutation and tissue. In aging tissue the average mutation burden across all copies stays low. What

rises is the number of individual cells that have crossed the threshold through clonal expansion of

a single mutant lineage.

The origin of those mutations was long assumed to be oxidative lesions. Deep sequencing of aged human brain instead found a mutational spectrum dominated by transitions consistent with errors made by the mitochondrial polymerase during replication.[^kennedy2013] Mice engineered with a proofreading-deficient version of that polymerase do age prematurely, but they carry mutation loads far above anything seen in normal aging, so the model demonstrates that enough mtDNA damage causes an aging-like phenotype rather than that normal aging is caused by mtDNA damage.

These mutations were long assumed to originate in oxidative lesions. Deep sequencing of aged human

brain instead found a mutational spectrum dominated by transitions, consistent with errors made by

the mitochondrial polymerase during replication.[^kennedy2013] Mice engineered with a

proofreading-deficient version of that polymerase do age prematurely, but they carry mutation loads

far above anything seen in normal aging. The model therefore shows that enough mtDNA damage causes

an aging-like phenotype; it does not show that mtDNA damage causes normal aging.

## Quality control

Damaged mitochondria are removed by mitophagy, a selective branch of [[autophagy]]. The best-characterized route depends on PINK1, which accumulates on depolarized mitochondria and recruits the ubiquitin ligase Parkin; receptor-mediated routes using BNIP3, NIX and FUNDC1 operate in parallel and dominate in some tissues. Both PINK1 and Parkin are mutated in familial early-onset Parkinson's disease, which is the strongest human evidence that failing mitochondrial quality control causes degeneration in a specific cell population.

Damaged mitochondria are removed by mitophagy, a selective branch of [[autophagy]]. The

best-characterized route depends on PINK1, which accumulates on depolarized mitochondria and

recruits the ubiquitin ligase Parkin. Receptor-mediated routes using BNIP3, NIX and FUNDC1 operate

in parallel and dominate in some tissues. PINK1 and Parkin are both mutated in familial early-onset

Parkinson's disease, the strongest human evidence that failing mitochondrial quality control causes

degeneration in a specific cell population.

Mitophagy is coupled to mitochondrial dynamics: fission separates damaged segments for disposal, fusion allows complementation between genomes. Markers of mitophagic flux decline with age in several model organisms, and "disabled macroautophagy" was added as a separate hallmark in 2023 in part because of this. Whether mitophagy declines with age in human tissue is harder to establish, since flux cannot be measured directly in a living person — the same measurement barrier that limits [[aging-biomarkers|biomarker]] development generally.

Mitophagy is coupled to mitochondrial dynamics: fission separates damaged segments for disposal, and

fusion allows complementation between genomes. Markers of mitophagic flux decline with age in

several model organisms, which is part of the reason "disabled macroautophagy" was added as a

separate hallmark in 2023. Whether mitophagy declines with age in human tissue is harder to

establish, since flux cannot be measured directly in a living person. The same measurement barrier

limits [[aging-biomarkers|biomarker]] development generally.

## Interventions

Exercise remains the most reliable stimulus of mitochondrial biogenesis and the only intervention with strong human functional evidence. Among drugs and supplements, urolithin A, a gut metabolite of ellagitannins, induces mitophagy in preclinical models and has been tested in humans; randomized trials in middle-aged and in older adults have reported modest improvements in muscle endurance measures without clear gains in aerobic capacity.[^singh2022][^liu2022] [[nad-precursors|NAD⁺ precursors]] are promoted partly on mitochondrial grounds, and raise blood NAD⁺ reliably while producing little demonstrated functional benefit. Elamipretide, a peptide that binds cardiolipin in the inner membrane, did not meet its primary endpoint in a phase 3 trial in primary mitochondrial myopathy, though it has continued in narrower indications.

Exercise remains the most reliable stimulus of mitochondrial biogenesis and the only intervention

with strong human functional evidence. Among drugs and supplements, urolithin A, a gut metabolite of

ellagitannins, induces mitophagy in preclinical models and has been tested in humans. Randomized

trials in middle-aged and in older adults have reported modest improvements in measures of muscle

endurance without clear gains in aerobic capacity.[^singh2022][^liu2022]

[[nad-precursors|NAD⁺ precursors]] are promoted partly on mitochondrial grounds; they raise blood

NAD⁺ reliably but have shown little functional benefit. Elamipretide, a peptide that binds

cardiolipin in the inner membrane, did not meet its primary endpoint in a phase 3 trial in primary

mitochondrial myopathy, though development has continued in narrower indications.

[[caloric-restriction|Dietary restriction]] and [[rapamycin]] both alter mitochondrial turnover, and part of their effect is attributed to enhanced quality control rather than to reduced damage. Mitochondrial-derived peptides such as humanin and MOTS-c have been proposed as signalling mediators between mitochondrial state and organismal metabolism; the human data are observational.

[[caloric-restriction|Dietary restriction]] and [[rapamycin]] both alter mitochondrial turnover, and

part of their effect is attributed to better quality control rather than to reduced damage.

Mitochondrial-derived peptides such as humanin and MOTS-c have been proposed as signals linking

mitochondrial state to organismal metabolism; the human data are observational.

## Transfer, replacement, and editing

Three approaches attempt to change mitochondria rather than support them. Autologous mitochondrial transplantation — injecting mitochondria isolated from a patient's own muscle into ischaemic heart tissue — has been performed in small paediatric case series at a single centre, with encouraging but uncontrolled results. [[mitochondrial-replacement-therapy|Mitochondrial replacement]] in the germline avoids transmitting pathogenic mtDNA by transferring nuclear material into a donor egg, and is legal in a small number of jurisdictions. Editing mtDNA directly is complicated by the fact that guide RNAs are not imported into mitochondria, which rules out standard CRISPR approaches; base editors built from a bacterial toxin that acts on double-stranded DNA have been used to install specific mtDNA edits in cells and mice, and are the leading route to a [[gene-therapy-for-aging|genetic intervention]] on the mitochondrial genome.

Three approaches try to change mitochondria instead of supporting them. In autologous mitochondrial

transplantation, mitochondria isolated from a patient's own muscle are injected into ischaemic heart

tissue. It has been performed in small paediatric case series at a single centre, with encouraging

but uncontrolled results. [[mitochondrial-replacement-therapy|Mitochondrial replacement]] in the

germline transfers nuclear material into a donor egg so that pathogenic mtDNA is not passed on, and

it is legal in a small number of jurisdictions. Editing mtDNA directly is complicated because guide

RNAs are not imported into mitochondria, which rules out standard CRISPR approaches. Base editors

built from a bacterial toxin that acts on double-stranded DNA have installed specific mtDNA edits in

cells and mice, and they are the leading route to a [[gene-therapy-for-aging|genetic intervention]]

on the mitochondrial genome.

Whether any of this addresses aging as opposed to specific mitochondrial diseases is unresolved. The clonal expansion that produces cytochrome-oxidase-negative fibres affects a minority of cells even in old muscle, and no one has shown that correcting it restores organ-level function in an aged mammal. That gap — between a well-documented molecular lesion and a demonstrated contribution to functional decline — is the standing problem for the hallmark, and it applies with equal force to [[cellular-senescence|senescence]] and [[proteostasis|proteostasis]] as causal accounts.

Whether any of this addresses aging, as opposed to specific mitochondrial diseases, is unresolved.

Even in old muscle, the clonal expansion that produces cytochrome-oxidase-negative fibres affects a

minority of cells, and no one has shown that correcting it restores organ-level function in an aged

mammal. The gap between a well-documented molecular lesion and a demonstrated contribution to

functional decline is the standing problem for this hallmark, and it applies with equal force to

[[cellular-senescence|senescence]] and [[proteostasis|proteostasis]] as causal accounts.

## See also

removed, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.

84 lines are the same in both revisions, and 36 of them are not shown. Neither revision here is necessarily the current article — read Mitochondrial dysfunction in aging for the text this wiki stands behind today.